Syed O Hasan
Examiner (ID: 9396, Phone: (571)272-0990 , Office: P/3747 )
Most Active Art Unit | 3747 |
Art Unit(s) | 3783, 3747 |
Total Applications | 907 |
Issued Applications | 710 |
Pending Applications | 53 |
Abandoned Applications | 143 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11954647
[patent_doc_number] => 20170258798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'INJECTION PREPARATION AND METHOD FOR PRODUCING SAME'
[patent_app_type] => utility
[patent_app_number] => 15/606594
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24966
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606594
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/606594 | Injection preparation and method for producing same | May 25, 2017 | Issued |
Array
(
[id] => 16533253
[patent_doc_number] => 10875836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Callyspongiolide, analogs thereof and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/304652
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12692
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304652
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304652 | Callyspongiolide, analogs thereof and uses thereof | May 25, 2017 | Issued |
Array
(
[id] => 14438839
[patent_doc_number] => 20190177291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => PROCESS FOR PREPARATION OF ERIBULIN AND INTERMEDIATES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/304470
[patent_app_country] => US
[patent_app_date] => 2017-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304470
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304470 | Process for preparation of eribulin and intermediates thereof | May 24, 2017 | Issued |
Array
(
[id] => 12979570
[patent_doc_number] => 20170342060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
[patent_app_type] => utility
[patent_app_number] => 15/603744
[patent_app_country] => US
[patent_app_date] => 2017-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23965
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 2470
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15603744
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/603744 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | May 23, 2017 | Abandoned |
Array
(
[id] => 11948192
[patent_doc_number] => 20170252344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'Compositions Containing Ibrutinib'
[patent_app_type] => utility
[patent_app_number] => 15/602989
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11192
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15602989
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/602989 | Compositions Containing Ibrutinib | May 22, 2017 | Abandoned |
Array
(
[id] => 14777737
[patent_doc_number] => 20190263766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => BIOMASS CONVERSION
[patent_app_type] => utility
[patent_app_number] => 16/304087
[patent_app_country] => US
[patent_app_date] => 2017-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12446
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16304087
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/304087 | Biomass conversion | May 22, 2017 | Issued |
Array
(
[id] => 12509160
[patent_doc_number] => 10000504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-19
[patent_title] => Pseudopolymorphic forms of a HIV protease inhibitor
[patent_app_type] => utility
[patent_app_number] => 15/600932
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 26
[patent_no_of_words] => 12045
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600932
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600932 | Pseudopolymorphic forms of a HIV protease inhibitor | May 21, 2017 | Issued |
Array
(
[id] => 12062080
[patent_doc_number] => 20170338424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'ORGANIC MATERIAL AND PHOTOELECTRIC CONVERSION ELEMENT'
[patent_app_type] => utility
[patent_app_number] => 15/596423
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11583
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15596423
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/596423 | Organic material and photoelectric conversion element | May 15, 2017 | Issued |
Array
(
[id] => 14342019
[patent_doc_number] => 20190152982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => POTENT AND SELECTIVE MU OPIOID RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/301765
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13003
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301765 | Potent and selective mu opioid receptor modulators | May 15, 2017 | Issued |
Array
(
[id] => 15915155
[patent_doc_number] => 10654806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Menthyl nicotinate synthesis process
[patent_app_type] => utility
[patent_app_number] => 16/072843
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3634
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072843 | Menthyl nicotinate synthesis process | May 14, 2017 | Issued |
Array
(
[id] => 12138147
[patent_doc_number] => 20180016225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'TETRACYCLINE COMPOUNDS HAVING TARGET THERAPEUTIC ACTIVITIES'
[patent_app_type] => utility
[patent_app_number] => 15/595267
[patent_app_country] => US
[patent_app_date] => 2017-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31797
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15595267
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/595267 | TETRACYCLINE COMPOUNDS HAVING TARGET THERAPEUTIC ACTIVITIES | May 14, 2017 | Abandoned |
Array
(
[id] => 11946194
[patent_doc_number] => 20170250345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'ORGANIC SEMICONDUCTOR ELEMENT, MANUFACTURING METHOD THEREOF, ORGANIC SEMICONDUCTOR COMPOSITION, ORGANIC SEMICONDUCTOR FILM, COMPOUND, AND OLIGOMER OR POLYMER'
[patent_app_type] => utility
[patent_app_number] => 15/593337
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17158
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15593337
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/593337 | Organic semiconductor element, manufacturing method thereof, organic semiconductor composition, organic semiconductor film, compound, and oligomer or polymer | May 11, 2017 | Issued |
Array
(
[id] => 16756473
[patent_doc_number] => 10975009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Selective reduction of aldehydes and ketones
[patent_app_type] => utility
[patent_app_number] => 16/300944
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8933
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300944 | Selective reduction of aldehydes and ketones | May 10, 2017 | Issued |
Array
(
[id] => 14306205
[patent_doc_number] => 20190142806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => MODULATORS OF THE INTEGRATED STRESS PATHWAY
[patent_app_type] => utility
[patent_app_number] => 16/098950
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45605
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098950 | Modulators of the integrated stress pathway | May 4, 2017 | Issued |
Array
(
[id] => 16642085
[patent_doc_number] => 10919921
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => P-chiral phosphine ligands and use thereof for asymmetric synthesis
[patent_app_type] => utility
[patent_app_number] => 16/099324
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22046
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 948
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099324 | P-chiral phosphine ligands and use thereof for asymmetric synthesis | May 4, 2017 | Issued |
Array
(
[id] => 14388307
[patent_doc_number] => 10307411
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Use of cotinine in treating or preventing neurogenesis deficits and enhancing neurogenesis
[patent_app_type] => utility
[patent_app_number] => 15/583937
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 19243
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583937
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583937 | Use of cotinine in treating or preventing neurogenesis deficits and enhancing neurogenesis | Apr 30, 2017 | Issued |
Array
(
[id] => 11993896
[patent_doc_number] => 20170298051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'ACTIVATOR OF ADIPONECTIN RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 15/581252
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 159
[patent_figures_cnt] => 159
[patent_no_of_words] => 28891
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581252 | ACTIVATOR OF ADIPONECTIN RECEPTOR | Apr 27, 2017 | Abandoned |
Array
(
[id] => 15200749
[patent_doc_number] => 10497881
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Organic semiconductor element, manufacturing method thereof, composition for forming organic semiconductor film, compound, and organic semiconductor film
[patent_app_type] => utility
[patent_app_number] => 15/497239
[patent_app_country] => US
[patent_app_date] => 2017-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 20475
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 349
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/497239 | Organic semiconductor element, manufacturing method thereof, composition for forming organic semiconductor film, compound, and organic semiconductor film | Apr 25, 2017 | Issued |
Array
(
[id] => 14929715
[patent_doc_number] => 20190300495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => NONIONIC SURFACTANT
[patent_app_type] => utility
[patent_app_number] => 16/308105
[patent_app_country] => US
[patent_app_date] => 2017-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308105 | Nonionic surfactant | Apr 20, 2017 | Issued |
Array
(
[id] => 16476180
[patent_doc_number] => 10851108
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-01
[patent_title] => Substituted bicyclic heterocyclic compounds
[patent_app_type] => utility
[patent_app_number] => 16/094288
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28960
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 463
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094288
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/094288 | Substituted bicyclic heterocyclic compounds | Apr 18, 2017 | Issued |